Introduction {#sec1}
============

Pyrido\[2,3-*b*\]indole, commonly referred to as α-carboline, is the core unit of several natural products^[@ref1]^ and pharmacologically active compounds endowed with cytotoxic, anticancer, antimalarial, antifungal, antibacterial, antioxidant, and anti-inflammatory activities ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref2]^ Given such importance, considerable efforts have been made into developing multiple strategies for the synthesis of pyrido\[2,3-*b*\]indole derivatives, which have been reviewed by Brimble et al. recently.^[@ref3],[@ref4]^ Simultaneously, many approaches for the synthesis of neocryptolepine, an important natural compound containing this structural motif, are also reported.^[@ref5]^ Unfortunately, most of these methods suffer from low atom economy, lack of substrate generality, use of highly functionalized starting materials, expensive transition metals, or harsh conditions, thereby underscoring the need for development of a general and efficient approach to this heterocycle.

![Representative natural and bioactive compounds containing pyrido\[2,3-*b*\]indole moiety.](ao-2019-00396v_0001){#fig1}

It is widely reported that a multicomponent reaction between isatin, α-amino acid, and dipolarophile offers spirooxindoles.^[@ref6]^ The reaction proceeds via imine formation between the amino acid and isatin, followed by decarboxylation of the amino acid to produce an azomethine ylide, which then undergoes 1,3-dipolar cycloaddition with a dipolarophile to afford the product. During the studies related to the Vilsmeier--Haack reaction of spiroindolones, Black et al. reported that heating 4′,6′-dimethoxyspiro\[\[1,3\]dithiolane-2,3′-indolin\]-2′-one with POCl~3~ in the presence of 4,6-dimethoxy-2,3-diphenyl-1*H*-indole afforded biindolyl ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).^[@ref7]^ This reaction was suggested to proceed via formation of 7,9-dimethoxy-3,6-dihydro-2*H*-\[1,4\]dithiino\[2,3-*b*\]indol-6-ylium intermediate, which underwent nucleophilic attack with 4,6-dimethoxy-2,3-diphenyl-1*H*-indole. Based on this report, we envisaged that spirooxindoles bearing a pyrroline ring may undergo similar ring expansion reaction with POCl~3~ to offer pyrido\[2,3-*b*\]indoles. Notably, the intermolecular and intramolecular aminations of amides with NH heterocycles, *N*-substituted anilines, or pyridine for preparing aza heterocycles using POCl~3~ are widely reported in the literature^[@ref8]^ ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Besides, it is cited that indolin-2-one furnishes a mixture of triindole and tetraindole in the presence of POCl~3~.^[@ref9]^ We reasoned that treating spirooxindole with POCl~3~ would produce an active intermediate **A**, which may undergo nucleophilic displacement with the pyrroline nitrogen to form intermediate **B** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Subsequently, an intramolecular rearrangement of intermediate **B** would result in 1-substituted-1*H*-α-carboline. To the best of our knowledge, there is a lack of report concerning synthesis of such new four-membered annulated heterocyclic system from spirooxindole, and therefore, we considered probing the envisaged reaction. Accordingly, the spirooxindole was prepared by the reaction between isatin, proline, and phenylacetylene, and treatment with POCl~3~ under heating resulted in the formation of pyrido\[2,3-*b*\]indole. This initial success prompted us to study the scope of this novel dehydrative transformation in detail and explore if pyrido\[2,3-*b*\]indoles could be prepared directly from isatin as a one-pot protocol. The details of the results pertaining to this study are presented herein.

![Previously reported strategies and the present work.](ao-2019-00396v_0002){#fig2}

![Proposed Pathway for the Synthesis of Pyrido\[2,3-*b*\]indole from Spirooxindole via Intramolecular Dehydration](ao-2019-00396v_0003){#sch1}

Results and Discussion {#sec2}
======================

Initially, a pilot reaction of isatin (**1a**) with proline (**2a**) and phenylacetylene (**3a**) in the presence of CuI in MeCN under heating afforded spirooxindole **4aaa**.^[@ref10]^ Subsequent reaction of **4aaa** with 20 equiv of POCl~3~ at 105 °C for 20 h resulted in isolation of a solid product (79%) that was spectrally established to be the expected 5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole **5aaa**. To improve the yield of **5aaa**, optimization of the protocol by titrating the amount of POCl~3~, modulating the temperature, and replacing POCl~3~ with other dehydrating agents was performed, and the results are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Lowering the temperature to 90 °C and reducing the amount of the POCl~3~ gave **5aaa** in a superior yield of 86%. Further lowering the temperature or the amount of POCl~3~, however, proved detrimental for the synthesis of **5aaa**. We observed that POBr~3~ gave comparable yield of **5aaa**, but PCl~5~, SOCl~2~, PPA, or P~2~O~5~ was ineffective for the protocol. Thus, the optimized condition for the synthesis of pyrido\[2,3-*b*\]indole from spirooxindole that worked best in our hands was reacting **4aaa** with 5 equiv of POCl~3~ at 90 °C for 24 h.

###### Results of the Optimization Study for Dehydrative Intramolecular Cyclization of Spirooxindole **4aaa**[a](#t1fn1){ref-type="table-fn"}

![](ao-2019-00396v_0010){#fx1}

  entry                                dehydrating agent (equiv)   temp. (°C)   time (h)   yield (%)[b](#t1fn2){ref-type="table-fn"} 5aaa
  ------------------------------------ --------------------------- ------------ ---------- ------------------------------------------------
  1                                    POCl~3~ (20)                105          20         79
  2                                    POCl~3~ (20)                90           24         85
  3                                    POCl~3~ (20)                70           30         81
  4                                    POCl~3~ (10)                90           24         86
  5                                    POCl~3~ (5.0)               90           24         86
  6                                    POCl~3~ (3.0)               90           24         65
  7                                    POBr~3~ (5.0)               90           24         84
  8                                    PCl~5~ (5.0)                90           24         0
  9                                    SOCl~2~ (5.0)               90           24         0
  10                                   PPA (5.0)                   90           24         0
  11[c](#t1fn3){ref-type="table-fn"}   P~2~O~5~ (5.0)              90           24         0

All reactions were performed using **4aaa** (0.5 mmol) in a sealed tube.

Isolated yield after column chromatography.

1.0 mL of toluene was used as the solvent.

With the standardized conditions identified, the scope of the reaction was investigated with a variety of spirooxindoles **4** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). The first set of spirooxindoles **4aab**--**4aak** were prepared from isatin **1a**, proline **2a**, and different acetylenes **3b**--**k** (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00396/suppl_file/ao9b00396_si_001.pdf) (SI) for details). It was found that all substrates smoothly afforded the corresponding products **5aab**--**5aak** in 78--87% yields, thereby reflecting that the protocol could accommodate aryl, heteroaryl, as well as aliphatic starting materials. In addition, the structures of these products were unambiguously secured by performing X-ray crystallographic analysis on a single crystal of **5aaf**. For the next set of reactions, spirooxindoles **4baa**--**4kaa** prepared from substituted isatins **1b**--**k**, proline **2a**, and phenylacetylene **3a** were used. It was pleasing to discover that all spirooxindoles underwent dehydrative transformation to afford the respective products **5baa**--**5kaa** in excellent yields ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). These results suggested that the electronic nature of the substitution on the isatin unit also had no impact on the outcome of the protocol. To demonstrate the essentiality of a free NH in the isatin unit for success in this transformation, **4laa** was prepared and subjected to reaction with POCl~3~, which resulted in decomposition of the starting material ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Scope of Synthesis of Substituted Pyrido\[2,3-*b*\]indoles (**5**) from Spirooxindoles (**4**)\
All reactions were performed using 0.5 mmol of **4** in a sealed tube.](ao-2019-00396v_0004){#sch2}

![Control Reaction](ao-2019-00396v_0005){#sch3}

Success of the protocol with a variety of substrates motivated us to explore the possibility of a one-pot, two-step process from isatin, thereby eliminating the need for isolation of the spirooxindole. Thus, in a model reaction, **1a**, **2a**, and **3a** were treated first with CuI in MeCN, followed by removal of the solvent and addition of POCl~3~ to the residue and heating the mixture for 24 h. This one-pot procedure afforded **5aaa** in 70% yield, which was relatively better than the overall yield of 67% obtained in the two-step procedure ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Buoyed by this success, we evaluated the one-pot syntheses of **5aaj**, **5aak**, **5baa**, and **5daa** and found that, in each case, yield of the product was better than the two-step process (for comparison, refer to the [SI](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00396/suppl_file/ao9b00396_si_001.pdf)).

![One-Pot Synthesis of Pyrido\[2,3-*b*\]indoles (**5**)^,^\
All reactions were performed using 1.0 mmol of **1**, 1.0 mmol of **2a**, 1.2 mmol of **3**, and 5 mmol of POCl~3~.\
8 mmol of POCl~3~ was used.](ao-2019-00396v_0006){#sch4}

Aiming at broadening the scope of the protocol, we next investigated the two-step, one-pot procedure with internal alkynes instead of terminal alkynes. The reaction of alkyne **3l** with **1a** and **2a** failed to afford the desired **5aal** in a one-pot process. Hence, we considered exploring reactions with activated alkynes since they are reported to offer spirooxindoles under metal-free conditions.^[@ref11]^ Accordingly, treating internal alkynes **3m**--**o** with **1a** and **2a** in methanol under metal-free condition successfully furnished the required spirooxindoles. Evaporating of solvent and treating the crude spirooxindoles with POCl~3~ at 90 °C furnished **5aam**, **5aan**, and **5aao** in 79--82% yield ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}).

![One-Pot Synthesis of Pyrido\[2,3-*b*\]indoles (**5**) from Internal Alkynes\
All reactions were performed using 1.0 mmol of **1a**, 1.0 mmol of **2a**, 1.0 mmol of **3**, and 5--10 mmol of POCl~3~.](ao-2019-00396v_0007){#sch5}

Further, we assessed the reaction of different α-amino acids (**2b**--**f**) with **1a** and **3m** to afford the title compounds. Notably, the selection of amino acids too was influenced by their ability to form spirooxindole.^[@ref11]^ Reaction of **1a** and **3m** with [l]{.smallcaps}-thioproline (**2b**) and sarcosine (**2e**) produced the corresponding products **5abm** and **5aem** in 68 and 77% yields, respectively ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). However, the reaction with *cis*-4-hydroxy-[d]{.smallcaps}-proline (**2c**) and pipecolinic acid (**2d**) resulted in a mixture of products, from which the desired product could not be isolated. We ascertained that reaction of **2c** with **1a** and **3m** successfully afforded spirooxindole as reported,^[@cit11a]^ but further treatment with POCl~3~ produced a complex mixture of products. Likewise, the reaction of glycine (**2f**) also failed to furnish the desired product **5afm**.

![Scope of the Reaction with α-Amino Acids\
All reactions were performed using 1.0 mmol of **1a**, 1.0 mmol of **2a**, 1.0 mmol of **3**, and 5--10 mmol of POCl~3~.](ao-2019-00396v_0008){#sch6}

Success with activated alkynes made it imperative to probe the reaction with activated alkenes as they too are known to afford spirooxindoles.^[@ref6],[@ref12]^ Therefore, in a representative experiment, reaction of dimethyl maleate (**3p**) with **1a** and **2a** was performed, which resulted in isolation of **5aam** in 76% yield, but 2 days were required for reaction completion ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). It was apparent that an in situ oxidation occurred in the final step to afford the observed product. Likewise, treating **1a** and **2a** with diethyl maleate (**3q**) led to the formation of **5aan** in 2 days, establishing the generality of the protocol. The scope was further investigated with 1,4-naphthoquinone (**3r**), benzylideneacetone (**3s**), and acrylonitrile (**3t**) and, in all cases, the expected products **5aar**, **5aas**, and **5aat** were isolated in 70--74% yields. It is worth mentioning that the structure of **5aas** was derived from the structure of the spirooxindole intermediate.^[@ref12]^

![Scope of the Reaction with Activated Alkenes^,^\
All reactions were performed using 1.0 mmol of **1a**, 1.0 mmol of **2a**, 1.0 mmol of **3**, and 5--10 mmol of POCl~3~.\
**5aam** = **5aap** and **5aan** = **5aaq**.](ao-2019-00396v_0009){#sch7}

Conclusions {#sec3}
===========

In summary, we have developed a POCl~3~-mediated dehydrative transformation of spirooxindoles into pyrido\[2,3-*b*\]indoles via ring expansion and construction of the pyridine ring. The transformation could be executed from either spiroxindole or as a two-step, one-pot protocol starting from isatin. This protocol, which involves the use of readily available starting materials, is versatile and accommodates terminal and activated internal alkynes as well as alkenes. The presence of different functional groups such as ester, nitrile, and acyl groups in the title compounds provides the opportunity to expand them further for investigating different biological activities. In this context, further work is underway to develop new analogues of fused α-carbolines.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

Thin-layer chromatography (TLC) on precoated silica gel plates was used to monitor all reactions. After elution, the TLC plate was visualized under UV illumination at 254 nm. All melting points were recorded on a hot-stage apparatus and are uncorrected. IR spectra were recorded on an Fourier-transform infrared spectrophotometer. ^1^H NMR and ^13^C NMR spectra were recorded on Bruker 300, 400, and 500 MHz spectrometers, using tetramethylsilane as an internal standard. Peak multiplicities of NMR signals were designated as s (singlet), d (doublet), dd (doublet of doublet), dt (doublet of triplet), t (triplet), q (quartet), or m (multiplet). The electrospray ionization mass spectrometry (ESI-MS) images were recorded on an ion trap mass spectrometer. The high resolution mass spectrometry (HRMS) images were recorded as ESI-HRMS images on a quadrupole time-of-flight LC-MS/MS mass spectrometer. Commercial grade reagents and solvents were used without further purification. The title compounds obtained from **3p** and **3q** are **5aam** and **5aan**, respectively. Therefore, there are no data for **5aap** and **5aaq**.

General Experimental Procedure for the Synthesis of Spirooxindole 4 as Exemplified for 4aaa {#sec4.2}
-------------------------------------------------------------------------------------------

In a round-bottom flask equipped with a water condenser, were added isatin **1a** (0.147 g, 1.0 mmol), [l]{.smallcaps}-proline **2a** (0.115 g, 1.0 mmol), phenylacetylene **3a** (132 μL, 1.2 mmol), and CuI (0.0095 g, 5 mol %) in 5 mL of acetonitrile. The reaction mixture was refluxed under nitrogen atmosphere for 6 h. After completion of the reaction (as monitored by TLC), the reaction mixture was cooled to room temperature and passed through a bed of celite. The filtrate was concentrated under reduced pressure to obtain the crude product, which was purified by column chromatography over silica gel using hexanes/EtOAc (30:70, v/v) as eluent to obtain 0.236 g (78%) of spirooxindole **4aaa** as a yellow solid.

### 2′-Phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4aaa**) {#sec4.2.1}

Mp 180--182 °C \[Lit:^[@cit10b]^ 180 °C\]; *R*~f~ = 0.42 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1721 (C=O), 3409 (N--H) cm^--1^. ^1^H NMR (300 MHz, CDCl~3~): δ (ppm) = 1.55--1.67 (m, 1H, CH), 1.81--1.91 (m, 2H, 2 × CH), 2.09--2.19 (m, 1H, CH), 2.68--2.81 (m, 2H, CH~2~), 4.75 (dt, *J* = 7.7, 1.7 Hz, 1H, N--CH), 6.58 (d, *J* = 1.9 Hz, 1H, =CH), 6.89--6.97 (m, 3H, ArH), 6.99--7.03 (m, 2H, ArH), 7.08--7.11 (m, 3H, ArH), 7.17--7.23 (m, 1H, ArH), 9.32 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.2, 31.9, 49.1, 71.6, 79.7, 111.1, 122.2, 126.3, 127.1, 127.7, 128.4, 129.7, 133.1, 133.5, 140.1, 141.9, 181.4. DEPT-135 (75 MHz, CDCl~3~): δ (ppm) = 27.2, 31.9, 49.1, 71.6, 111.1, 122.3, 126.3, 127.1, 127.8, 128.5, 129.8, 133.1. MS (ESI+): *m*/*z* = 303.1. ESI-HR-MS calculated for C~20~H~18~N~2~O \[MH\]^+^: 303.1492, found: 303.1492.

### 2′-(*p*-Tolyl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4aab**) {#sec4.2.2}

Yield: 67% (0.212 g from 0.147 g of **1a**) as a yellow solid, mp 213--215 °C; *R*~f~ = 0.43 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1711 (C=O), 3490 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.55--1.65 (m, 1H, CH), 1.83--1.89 (m, 2H, 2 × CH), 2.09--2.16 (m, 1H, CH), 2.20 (s, 3H, CH~3~), 2.71--2.76 (m, 2H, CH~2~), 4.71--4.75 (m, 1H, N--CH), 6.53 (d, *J* = 1.8 Hz, 1H, =CH), 6.90--6.98 (m, 7H, ArH), 7.21 (dt, *J* = 7.6, 1.3 Hz, 1H, ArH), 9.21 (s, 1H, NH); ^13^C NMR (75 MHz, CDCl~3~): δ (ppm) = 21.2, 27.2, 31.9, 49.1, 71.6, 79.7, 111.1, 122.2, 126.2, 127.1, 127.2, 129.2, 129.7, 130.6, 132.1, 137.5, 139.9, 141.9, 181.3. MS (ESI+): *m*/*z* = 317.2. ESI-HR-MS calculated for C~21~H~20~N~2~O \[MH\]^+^: 317.1648, found: 317.1648.

### 2′-(4-(*tert*-Butyl)phenyl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4aac**) {#sec4.2.3}

Yield: 70% (0.251 g from 0.147 g of **1a**) as a yellow solid, mp 204--207 °C; *R*~f~ = 0.40 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1712 (C=O), 3446 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.19 (s, 9H, 3 × CH~3~), 1.56--1.65 (m, 1H, CH), 1.85--1.91 (m, 2H, 2 × CH), 2.10--2.17 (m, 1H, CH), 2.75 (t, *J* = 6.9 Hz, 2H, CH~2~), 4.72--4.77 (m, 1H, N--CH), 6.55 (d, *J* = 1.9 Hz, 1H, =CH), 6.91--7.01 (m, 5H, ArH), 7.09 (s, 1H, ArH), 7.12 (s, 1H, ArH), 7.22 (dd, *J* = 7.4, 1.1 Hz, 1H, ArH), 9.09 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.2, 31.2, 31.9, 34.5, 49.1, 71.6, 79.5, 111.2, 122.3, 125.4, 125.9, 127.0, 127.1, 129.9, 130.2, 131.9, 139.6, 142.0, 150.7, 180.8. MS (ESI+): *m*/*z* = 359.2. ESI-HR-MS calculated for C~24~H~26~N~2~O \[MH\]^+^: 359.2118, found: 359.2115.

### 2′-(*m*-Tolyl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4aad**) {#sec4.2.4}

Yield: 65% (0.205 g from 0.147 g of **1a**) as a yellow solid, mp 221--225 °C; *R*~f~ = 0.44 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1737 (C=O), 3415 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.48--1.58 (m, 1H, CH), 1.77--1.83 (m, 2H, 2 × CH), 2.02--2.08 (m, 1H, CH), 2.09 (s, 3H, CH~3~), 2.62--2.72 (m, 2H, CH~2~), 4.64--4.68 (m, 1H, N--CH), 6.48 (d, *J* = 1.9 Hz, 1H, =CH), 6.64 (d, *J* = 7.5 Hz, 1H, ArH), 6.83--6.92 (m, 6H, ArH), 7.14 (dt, *J* = 1.3 Hz, 1H, ArH), 9.03 (s, 1H, NH); ^13^C NMR (75 MHz, CDCl~3~): δ (ppm) = 21.5, 27.2, 31.9, 49.1, 71.5, 79.7, 111.0, 122.2, 123.2, 127.1, 127.3, 128.3, 128.6, 129.7, 132.9, 133.4, 137.8, 140.2, 142.0, 181.2. MS (ESI+): *m*/*z* = 317.2. ESI-HR-MS calculated for C~21~H~20~N~2~O \[MH\]^+^: 317.1648, found: 317.1648.

### 2′-(3-Fluorophenyl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4aae**) {#sec4.2.5}

Yield: 68% (0.217 g from 0.147 g of **1a**) as a yellow solid, mp 190--192 °C; *R*~f~ = 0.32 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1739 (C=O), 3435 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.49--1.56 (m, 1H, CH), 1.77--1.83 (m, 2H, 2 × CH), 2.04--2.11 (m, 1H, CH), 2.62--2.72 (m, 2H, CH~2~), 4.67 (t, *J* = 7.0 Hz, 1H, N--CH), 6.53 (d, *J* = 1.9 Hz, 1H, =CH), 6.65--6.76 (m, 3H, ArH), 6.86--6.92 (m, 3H, ArH), 6.95--7.01 (m, 1H, ArH), 7.14--7.19 (m, 1H, ArH), 9.02 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.2, 31.8, 49.1, 71.5, 79.6, 111.3, 113.3 (d, *J* = 22.4 Hz), 114.7 (d, *J* = 21.2 Hz), 121.9, 122.4, 126.7, 126.9, 129.9, 130.1, 134.3, 135.7 (d, *J* = 7.7 Hz), 139.1, 142.0, 162.7 (d, *J* = 245.3 Hz), 181.4. MS (ESI+): *m*/*z* = 321.1. ESI-HR-MS calculated for C~20~H~17~FN~2~O \[MH\]^+^: 321.1398, found: 321.1394.

### 2′-(2-(Trifluoromethyl)phenyl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2- one (**4aaf**) {#sec4.2.6}

Yield: 65% (0.241 g from 0.147 g of **1a**) as a yellow solid, mp 178--180 °C; *R*~f~ = 0.52 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1736 (C=O), 3416 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.78--1.92 (m, 3H, CH, CH~2~), 2.16--2.22 (m, 1H, CH), 2.69--2.73 (m, 1H, CH), 2.98--3.04 (m, 1H, CH), 4.88 (t, *J* = 7.3 Hz, 1H, N--CH), 6.41 (s, 1H, =CH), 6.83--6.86 (m, 2H, ArH), 7.06 (d, *J* = 7.6 Hz, 1H, ArH), 7.10--7.14 (m, 2H, ArH), 7.18--7.27 (m, 2H, ArH), 7.57 (d, *J* = 7.6 Hz, 1H, ArH), 9.58 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 26.1, 30.5, 50.5, 71.1, 81.3, 110.6, 122.1, 123.0, 125.6, 126.6, 126.7, 127.4, 128.0, 128.2, 129.7, 131.6, 133.8, 135.5, 139.3, 142.2, 181.0. MS (ESI+): *m*/*z* = 371.1. ESI-HR-MS calculated for C~21~H~17~F~3~N~2~O \[MH\]^+^: 371.1366, found: 371.1369.

### 2′-(Phenanthren-9-yl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4aag**) {#sec4.2.7}

Yield: 58% (0.234 g from 0.147 g of **1a**) as a brown solid, mp 176--179 °C; *R*~f~ = 0.41 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1719 (C=O), 3429 (N--H) cm^--1^. ^1^H NMR (400 MHz, DMSO-*d*~6~): δ (ppm) = 1.77--1.87 (m, 2H, 2 × CH), 1.97--2.00 (m, 1H, CH), 2.16--2.20 (m, 1H, CH), 2.56--2.60 (m, 1H, CH), 2.92--2.97 (m, 1H, CH), 4.69 (t, *J* = 6.5 Hz, 1H, N--CH), 6.40 (s, 1H, =CH), 6.61 (d, *J* = 7.6 Hz, 1H, ArH), 6.80 (t, *J* = 7.3 Hz, 1H, ArH), 7.04 (t, *J* = 7.4 Hz, 1H, ArH), 7.23 (s, 1H, ArH), 7.25 (s, 1H, ArH), 7.54--7.67 (m, 5H, ArH), 8.32--8.34 (m, 1H, ArH), 8.71--8.77 (m, 2H, ArH), 10.26 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~ + DMSO-*d*~6~): δ (ppm) = 27.2, 31.8, 49.1, 72.2, 82.0, 110.2, 121.1, 122.5, 122.6, 122.7, 122.8, 125.7, 126.1, 126.6, 126.7, 126.9, 127.0, 127.2, 128.5, 129.4, 130.0, 130.6, 130.8, 130.9, 136.9, 137.7, 143.0, 179.2. MS (ESI+): *m*/*z* = 403.2. ESI-HR-MS calculated for C~28~H~22~N~2~O \[MH\]^+^: 403.1805, found: 403.1804.

### 2′-(Pyridin-2-yl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4aah**) {#sec4.2.8}

Yield: 63% (0.191 g from 0.147 g of **1a**) as a yellow solid, mp 222--224 °C; *R*~f~ = 0.15 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1716 (C=O), 3402 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.60--1.69 (m, 1H, CH), 1.83--1.90 (m, 2H, 2 × CH), 2.10--2.18 (m, 1H, CH), 2.74 (t, *J* = 6.9 Hz, 2H, CH~2~), 4.79--4.83 (m, 1H, N--CH), 6.81--6.93 (m, 4H, ArH), 6.99 (d, *J* = 1.9 Hz, 1H, =CH), 7.12--7.17 (m, 2H, ArH), 7.40--7.44 (m, 1H, ArH), 8.24 (d, *J* = 4.1 Hz, 1H, ArH), 9.49 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.3, 31.8, 48.8, 72.2, 78.8, 110.7, 120.3, 121.5, 122.0, 126.1, 127.6, 129.3, 135.3, 135.9, 141.0, 142.7, 149.2, 151.7, 181.7. MS (ESI+): *m*/*z* = 304.1. ESI-HR-MS calculated for C~19~H~17~N~3~O \[MH\]^+^: 304.1444, found: 304.1440.

### 2′-(Thiophen-2-yl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4aai**) {#sec4.2.9}

Yield: 59% (0.182 g from 0.147 g of **1a**) as a yellow solid, mp 225--229 °C; *R*~f~ = 0.30 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1720 (C=O), 3410 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.48--1.59 (m, 1H, CH), 1.75--1.85 (m, 2H, 2 × CH), 2.01--2.09 (m, 1H, CH), 2.63--2.77 (m, 2H, CH~2~), 4.65 (t, *J* = 7.2 Hz, 1H, N--CH), 6.31 (d, *J* = 3.3 Hz, 1H, ArH), 6.43 (d, *J* = 1.4 Hz, 1H, =CH), 6.63--6.65 (m, 1H, ArH), 6.89--7.00 (m, 4H, ArH), 7.19--7.23 (m, 1H, ArH), 9.04 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.2, 31.8, 48.9, 71.8, 79.6, 111.0, 122.2, 124.1, 124.7, 126.4, 127.2, 127.3, 130.0, 131.6, 134.0, 136.1, 142.1, 180.7. MS (ESI+): *m*/*z* = 309.1. ESI-HR-MS calculated for C~18~H~16~N~2~OS \[MH\]^+^: 309.1056, found: 309.1054.

### 2′-(Cyclohex-1-en-1-yl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4aaj**) {#sec4.2.10}

Yield: 73% (0.224 g from 0.147 g of **1a**) as a yellow solid, mp 182--183 °C; *R*~f~ = 0.30 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1718 (C=O), 3359 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.39--1.63 (m, 5H, CH, 2 × CH~2~), 1.74--1.89 (m, 4H, 2 × CH~2~), 2.03--2.08 (m, 2H, 2 × CH), 2.21--2.25 (m, 1H, CH), 2.61 (t, *J* = 6.9 Hz, 2H, CH~2~), 4.59 (t, *J* = 7.7 Hz, 1H, N--CH), 5.00 (t, *J* = 4.1 Hz, 1H, =CH), 6.16 (s, 1H, =CH), 6.92 (d, *J* = 7.7 Hz, 1H, ArH), 6.95--7.00 (m, 2H, ArH), 7.21--7.25 (m, 1H, ArH), 8.71 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 21.9, 22.6, 25.7, 26.9, 27.1, 31.9, 48.9, 71.2, 78.8, 110.9, 122.1, 126.1, 126.7, 128.2, 129.4, 129.9, 130.1, 141.2, 141.7, 181.8. MS (ESI+): *m*/*z* = 307.2. ESI-HR-MS calculated for C~20~H~22~N~2~O \[MH\]^+^: 307.1805, found: 307.1802.

### Methyl 2-Oxo-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizine\]-2′-carboxylate (**4aak**) {#sec4.2.11}

Yield: 69% (0.196 g from 0.147 g of **1a**) as an off-white solid, mp 179--182 °C; *R*~f~ = 0.32 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1708 (C=O), 3437 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.57--1.64 (m, 1H, CH), 1.85--1.89 (m, 2H, 2 × CH), 2.11--2.13 (m, 1H, CH), 2.72 (t, *J* = 6.1 Hz, 2H, CH~2~), 3.54 (s, 3H, CH~3~), 4.71 (t, *J* = 6.9 Hz, 1H, N--CH), 6.91--7.00 (m, 3H, ArH), 7.21--7.26 (m, 2H, =CH, ArH), 8.48 (s, 1H, NH); ^13^C NMR (75 MHz, CDCl~3~): δ (ppm) = 27.6, 31.4, 48.5, 51.8, 72.4, 110.8, 122.0, 126.0, 126.7, 129.9, 134.2, 142.2, 146.8, 162.7, 180.1. MS (ESI+): *m*/*z* = 285.1. ESI-HR-MS calculated for C~16~H~16~N~2~O~3~ \[MH\]^+^: 285.1234, found: 285.1238.

### 5-Methyl-2′-phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4baa**) {#sec4.2.12}

Yield: 74% (0.234 g from 0.161 g of **1b**) as an off-white solid, mp 189--193 °C; *R*~f~ = 0.35 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1723 (C=O), 3428 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.55--1.65 (m, 1H, CH), 1.85--1.88 (m, 2H, 2 × CH), 2.10--2.17 (m, 1H, CH), 2.22 (s, 3H, CH~3~), 2.68--2.79 (m, 2H, CH~2~), 4.73 (t, *J* = 7.3 Hz, 1H, N--CH), 6.59 (s, 1H, =CH), 6.77 (s, 1H, ArH), 6.83 (d, *J* = 7.8 Hz, 1H, ArH), 6.99--7.03 (m, 3H, ArH), 7.10--7.12 (m, 3H, ArH), 9.22 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 21.1, 27.1, 31.8, 48.8, 71.4, 79.6, 110.6, 126.2, 126.9, 127.5, 128.3, 130.0, 131.4, 132.7, 133.4, 139.4, 140.0, 181.2. MS (ESI+): *m*/*z* = 317.2. ESI-HR-MS calculated for C~21~H~20~N~2~O \[MH\]^+^: 317.1648, found: 317.1643.

### 5-Methoxy-2′-phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4caa**) {#sec4.2.13}

Yield: 75% (0.249 g from 0.177 g of **1c**) as a yellow solid, mp 206--209 °C; *R*~f~ = 0.20 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1720 (C=O), 3401 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.47--1.57 (m, 1H, CH), 1.76--1.85 (m, 2H, 2 × CH), 2.03--2.10 (m, 1H, CH), 2.65--2.71 (m, 2H, CH~2~), 3.63 (s, 3H, OCH~3~), 4.64--4.68 (m, 1H, N--CH), 6.50--6.51 (m, 2H, =CH, ArH), 6.65--6.68 (m, 1H, ArH), 6.78 (d, *J* = 8.4 Hz, 1H, ArH), 6.95--6.98 (m, 2H, ArH), 7.02--7.05 (m, 3H, ArH), 9.08 (s, 1H, NH); ^13^C NMR (125 MHz, CDCl~3~): δ (ppm) = 27.3, 32.0, 48.9, 55.8, 71.7, 80.1, 111.3, 113.9, 114.4, 126.3, 127.7, 128.4, 132.9, 133.4, 135.4, 140.1, 155.5, 181.3. MS (ESI+): *m*/*z* = 333.2. ESI-HR-MS calculated for C~21~H~20~N~2~O~2~ \[MH\]^+^: 333.1598, found: 333.1597.

### 5-Bromo-2′-phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4daa**) {#sec4.2.14}

Yield: 74% (0.282 g from 0.226 g of **1d**) as an off-white solid, mp 230--234 °C; *R*~f~ = 0.48 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1732 (C=O), 3427 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.56--1.66 (m, 1H, CH), 1.86--1.92 (m, 2H, 2 × CH), 2.11--2.18 (m, 1H, CH), 2.70--2.74 (m, 2H, CH~2~), 4.70--4.74 (m, 1H, N--CH), 6.59 (d, *J* = 1.9 Hz, 1H, =CH), 6.83 (d, *J* = 8.3 Hz, 1H, ArH), 6.99--7.02 (m, 2H, ArH), 7.07 (d, *J* = 1.8 Hz, 1H, ArH), 7.13--7.14 (m, 3H, ArH), 7.34 (dd, *J* = 8.3, 1.9 Hz, 1H, ArH), 9.41 (s, 1H, NH); ^13^C NMR (75 MHz, CDCl~3~ + DMSO-*d*~6~): δ (ppm) = 27.2, 31.7, 48.8, 71.5, 79.4, 112.2, 114.4, 126.1, 127.7, 128.4, 129.2, 129.6, 132.4, 133.1, 133.2, 139.6, 141.5, 180.1. MS (ESI+): *m*/*z* = 381.1. ESI-HR-MS calculated for C~20~H~17~BrN~2~O \[MH\]^+^: 381.0597, found: 381.0597.

### 5-Chloro-2′-phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4eaa**) {#sec4.2.15}

Yield: 73% (0.246 g from 0.181 g of **1e**) as an off-white solid, mp 220--224 °C; *R*~f~ = 0.47 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1731 (C=O), 3436 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.56--1.59 (m, 1H, CH), 1.84--1.94 (m, 2H, 2 × CH), 2.12--2.19 (m, 1H, CH), 2.71--2.74 (m, 2H, CH~2~), 4.73 (t, *J* = 7.2 Hz, 1H, N--CH), 6.59 (d, *J* = 1.7 Hz, 1H, =CH), 6.87 (d, *J* = 8.3 Hz, 1H, ArH), 6.94 (d, *J* = 1.8 Hz, 1H, ArH), 6.99--7.02 (m, 2H, ArH), 7.13--7.14 (m, 3H, ArH), 7.19 (dd, *J* = 8.3, 1.9 Hz, 1H, ArH), 9.29 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~ + DMSO-*d*~6~): δ (ppm) = 27.0, 31.5, 48.6, 71.2, 79.1, 111.5, 125.9, 126.6, 127.5, 128.2, 128.7, 129.4, 132.9, 133.2, 139.5, 141.4, 179.6. MS (ESI+): *m*/*z* = 337.1. ESI-HR-MS calculated for C~20~H~17~ClN~2~O \[MH\]^+^: 337.1102, found: 337.1105.

### 5-Fluoro-2′-phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4faa**) {#sec4.2.16}

Yield: 72% (0.231 g from 0.165 g of **1f**) as an off-white solid, mp 207--211 °C; *R*~f~ = 0.45 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1732 (C=O), 3442 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.54--1.64 (m, 1H, CH), 1.84--1.92 (m, 2H, 2 × CH), 2.12--2.19 (m, 1H, CH), 2.72--2.76 (m, 2H, CH~2~), 4.74 (t, *J* = 7.2 Hz, 1H, N--CH), 6.59 (d, *J* = 1.6 Hz, 1H, =CH), 6.71 (dd, *J* = 7.8, 2.3 Hz, 1H, ArH), 6.85--6.94 (m, 2H, ArH), 7.00--7.03 (m, 2H, ArH), 7.12--7.13 (m, 3H, ArH), 9.73 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.2, 31.9, 49.0, 71.7, 80.0, 111.7 (d, *J* = 7.8 Hz), 114.6 (d, *J* = 24.3 Hz), 116.3 (d, *J* = 23.5 Hz), 126.2, 127.9, 128.6, 128.8 (d, *J* = 7.2 Hz), 133.1, 133.3, 137.9, 139.7, 158.9 (d, *J* = 241.1 Hz), 181.7. MS (ESI+): *m*/*z* = 321.1. ESI-HR-MS calculated for C~20~H~17~FN~2~O \[MH\]^+^: 321.1398, found: 321.1394.

### 5-Nitro-2′-phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4gaa**) {#sec4.2.17}

Yield: 71% (0.247 g from 0.192 g of **1g**) as a yellow solid, mp 193--196 °C; *R*~f~ = 0.28 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1739 (C=O), 3435 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~ + DMSO-*d*~6~): δ (ppm) = 1.62--1.71 (m, 1H, CH), 1.80--1.91 (m, 2H, 2 × CH), 2.14--2.20 (m, 1H, CH), 2.67--2.71 (m, 2H, CH~2~), 4.68 (t, *J* = 7.3 Hz, 1H, N--CH), 6.63 (s, 1H, =CH), 6.97--6.98 (m, 2H, ArH), 7.06 (d, *J* = 8.5 Hz, 1H, ArH), 7.13--7.14 (m, 2H, ArH), 7.72--7.73 (m, 1H, ArH), 7.77 (d, *J* = 1.9 Hz, 1H, ArH), 8.16--8.19 (m, 1H, ArH), 11.03 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~ + DMSO-*d*~6~): δ (ppm) = 26.6, 30.9, 48.7, 70.9, 77.8, 110.5, 121.6, 125.6, 127.1, 127.4, 127.7, 128.5, 132.9, 134.3, 138.2, 141.9, 149.3, 179.0. MS (ESI+): *m*/*z* = 348.1. ESI-HR-MS calculated for C~20~H~17~N~3~O~3~ \[MH\]^+^: 348.1343, found: 348.1348.

### 2′-Phenyl-5-(trifluoromethoxy)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4haa**) {#sec4.2.18}

Yield: 79% (0.305 g from 0.231 g of **1h**) as a white solid, mp 221--223 °C; *R*~f~ = 0.59 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1732 (C=O), 3448 (N--H) cm^--1^. ^1^H NMR (500 MHz, CDCl~3~): δ (ppm) = 1.58--1.63 (m, 1H, CH), 1.88--1.89 (m, 2H, 2 × CH), 2.15--2.16 (m, 1H, CH), 2.67--2.75 (m, 2H, CH~2~), 4.74 (t, *J* = 6.6 Hz, 1H, N--CH), 6.57 (s, 1H, =CH), 6.86--7.12 (m, 8H, ArH), 9.41 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.1, 31.8, 49.0, 71.7, 79.9, 111.5, 120.8, 123.0, 126.3, 128.0, 128.6, 133.1, 133.6, 139.7, 140.6, 144.4, 181.5. MS (ESI+): *m*/*z* = 387.1. ESI-HR-MS calculated for C~21~H~17~F~3~N~2~O~2~ \[MH\]^+^: 387.1315, found: 387.1319.

### 7-Bromo-2′-phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4iaa**) {#sec4.2.19}

Yield: 72% (0.275 g from 0.226 g of **1i**) as a yellow solid, mp 219--222 °C; *R*~f~ = 0.35 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1732 (C=O), 3417 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.55--1.67 (m, 1H, CH), 1.84--1.89 (m, 2H, 2 × CH), 2.10--2.17 (m, 1H, CH), 2.68--2.72 (m, 2H, CH~2~), 4.69--4.73 (m, 1H, N--CH), 6.54 (d, *J* = 1.8 Hz, 1H, =CH), 6.85 (t, *J* = 8.00 Hz, 1H, ArH), 6.92--6.99 (m, 3H, ArH), 7.12--7.14 (m, 3H, ArH), 7.37 (d, *J* = 8.1, 1.0 Hz, 1H, ArH), 7.56 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.2, 31.6, 49.1, 71.5, 80.6, 103.6, 123.4, 126.0, 126.4, 127.8, 128.5, 132.4, 133.4, 133.7, 139.7, 140.9, 179.5. MS (ESI+): *m*/*z* = 381.1. ESI-HR-MS calculated for C~20~H~17~BrN~2~O \[MH\]^+^: 381.0597, found: 381.0598.

### 2′-Phenyl-7-(trifluoromethyl)-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4jaa**) {#sec4.2.20}

Yield: 70% (0.259 g from 0.215 g of **1j**) as a yellow solid, mp 242--246 °C; *R*~f~ = 0.52 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1730 (C=O), 3437 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.58--1.62 (m, 1H, CH), 1.85--1.90 (m, 2H, 2 × CH), 2.12--2.19 (m, 1H, CH), 2.67--2.70 (m, 2H, CH~2~), 4.74 (t, *J* = 7.2 Hz, 1H, N--CH), 6.56 (s, 1H, =CH), 6.95--6.96 (m, 2H, ArH), 7.04 (t, *J* = 7.7 Hz, 1H, ArH), 7.12--7.14 (m, 4H, ArH), 7.45 (d, *J* = 7.9 Hz, 1H, ArH), 7.74 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 27.0, 31.4, 49.1, 71.2, 78.0, 121.9, 126.1, 126.4, 127.8, 128.4, 128.5, 130.5, 133.2, 134.0, 138.9, 139.4, 178.7. MS (ESI+): *m*/*z* = 371.1. ESI-HR-MS calculated for C~21~H~17~F~3~N~2~O \[MH\]^+^: 371.1366, found: 371.1360.

### 5,7-Dimethyl-2′-phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4kaa**) {#sec4.2.21}

Yield: 72% (0.238 g from 0.175 g of **1k**) as a yellow solid, mp 229--231 °C; *R*~f~ = 0.45 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1714 (C=O), 3389 (N--H) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.56--1.65 (m, 1H, CH), 1.83--1.90 (m, 1H, CH), 2.09--2.16 (m, 1H, CH), 2.20 (s, 3H, CH~3~), 2.22 (s, 3H, CH~3~), 2.28--2.40 (m, 1H, CH), 2.67--2.79 (m, 2H, CH~2~), 4.71--4.75 (m, 1H, N--CH), 6.53 (d, *J* = 1.9 Hz, 1H, =CH), 6.63 (s, 1H, ArH), 6.86 (s, 1H, ArH), 6.98--7.00 (m, 2H, ArH), 7.08--7.11 (m, 3H, ArH), 8.32 (s, 1H, NH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 16.5, 21.2, 27.1, 31.7, 49.1, 71.3, 79.9, 119.6, 125.1, 126.3, 126.5, 127.6, 128.4, 131.4, 131.7, 133.0, 133.7, 138.1, 140.1, 180.7. MS (ESI+): *m*/*z* = 331.2. ESI-HR-MS calculated for C~22~H~22~N~2~O \[MH\]^+^: 331.1805, found: 331.1810.

### 1-Methyl-2′-phenyl-5′,6′,7′,7*a*′-tetrahydrospiro\[indoline-3,3′-pyrrolizin\]-2-one (**4laa**) {#sec4.2.22}

Yield: 75% (0.237 g from 0.161 g of **1l**) as a white solid, mp 178--181 °C; *R*~f~ = 0.45 (hexanes/EtOAc, 3:7, v/v); IR (KBr) ν~max~: 1725 (C=O) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.56--1.66 (m, 1H, CH), 1.82--1.89 (m, 2H, 2 × CH), 2.09--2.16 (m, 1H, CH), 2.63--2.68 (m, 1H, CH), 2.71--2.77 (m, 1H, CH), 3.23 (s, 3H, N--CH~3~), 4.73 (dt, *J* = 7.7, 1.8 Hz, 1H, N--CH), 6.51 (d, *J* = 1.9 Hz, 1H, =CH), 6.85 (d, *J* = 7.8 Hz, 1H, ArH), 6.87--6.90 (m, 2H, ArH), 6.94--6.97 (m, 1H, ArH), 7.01--7.03 (m, 1H, ArH), 7.05--7.08 (m, 3H, ArH), 7.27--7.31 (m, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 26.5, 26.9, 31.5, 49.1, 71.1, 79.0, 108.4, 122.1, 126.2, 126.4, 126.8, 127.4, 128.1, 129.6, 133.3, 133.7, 140.1, 144.5, 177.9. MS (ESI+): *m*/*z* = 317.2. ESI-HR-MS calculated for C~21~H~20~N~2~O \[MH\]^+^: 317.1648, found: 317.1646.

General Experimental Procedure for the Synthesis of 2,3-Dihydro-1*H*-indolizino\[5,6-*b*\]indoles 5 as Exemplified for **5aaa** {#sec4.3}
-------------------------------------------------------------------------------------------------------------------------------

A sealed tube charged with a mixture of spirooxindole (**4aaa**) (0.151 g, 0.5 mmol) and POCl~3~ (234 μL, 2.5 mmol) was heated at 90 °C for 24 h under stirring. On completion of the reaction (as assessed by TLC), the reaction mixture was neutralized by adding saturated NaHCO~3~ solution and extracted with EtOAc (50 mL × 2). The organic layers were pooled, dried over anhydrous Na~2~SO~4~, and evaporated to obtain a crude product, which was purified by column chromatography over silica gel using EtOAc/MeOH (80:20, v/v) as eluent to obtain 0.122 g (86%) of **5aaa** as a yellow solid.

### 5-Phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aaa**) {#sec4.3.1}

Mp 257--260 °C; *R*~f~ = 0.45 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.43--2.50 (m, 2H, CH~2~), 3.37 (t, *J* = 7.7 Hz, 2H, CH~2~), 4.77 (t, *J* = 7.4 Hz, 2H, CH~2~), 6.66 (s, 1H, ArH), 6.92 (t, *J* = 7.2 Hz, 1H, ArH), 7.35--7.39 (m, 1H, ArH), 7.45--7.52 (m, 3H, ArH), 7.57 (d, *J* = 7.9 Hz, 1H, ArH), 7.62--7.64 (m, 2H, ArH), 7.74 (d, *J* = 8.2 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.3, 31.7, 51.0, 105.0, 118.1, 118.6, 120.7, 121.9, 123.2, 127.2, 128.7, 128.8, 129.1, 138.7, 146.1, 146.6, 152.3, 154.0. MS (ESI+): *m*/*z* = 285.1. ESI-HR-MS calculated for C~20~H~16~N~2~ \[MH\]^+^: 285.1386, found: 285.1387.

### 5-(*p*-Tolyl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aab**) {#sec4.3.2}

Yield: 85% (0.127 g from 0.158 g) as a yellow solid, mp 202--204 °C; *R*~f~ = 0.41 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =2.47--2.55 (m, 5H, CH~3~, CH~2~), 3.41 (t, *J* = 7.6 Hz, 2H, CH~2~), 4.82 (t, *J* = 7.3 Hz, 2H, CH~2~), 6.71 (s, 1H, ArH), 6.99 (t, *J* = 7.3 Hz, 1H, ArH), 7.37 (d, *J* = 7.9 Hz, 2H, ArH), 7.43 (t, *J* = 7.2 Hz, 1H, ArH), 7.59--7.61 (m, 2H, ArH), 7.70 (d, *J* = 7.9 Hz, 1H, ArH), 7.81 (d, *J* = 8.1 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 21.4, 22.2, 31.6, 51.1, 105.3, 117.8, 118.6, 120.4, 121.8, 123.0, 127.0, 128.5, 129.4, 135.6, 139.1, 146.1, 146.9, 151.9, 153.4. MS (ESI+): *m*/*z* = 299.2. ESI-HR-MS calculated for C~21~H~18~N~2~ \[MH\]^+^: 299.1543, found: 299.1538.

### 5-(4-(*tert*-Butyl)phenyl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aac**) {#sec4.3.3}

Yield: 87% (0.148 g from 0.179 g) as a yellow solid, mp 224--226 °C; *R*~f~ = 0.50 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (500 MHz, CDCl~3~): δ (ppm) =1.43 (s, 9H, 3 × CH~3~), 2.51--2.54 (m, 2H, CH~2~), 3.42 (t, *J* = 7.0 Hz, 2H, CH~2~), 4.89 (t, *J* = 6.5 Hz, 2H, CH~2~), 6.78 (s, 1H, ArH), 7.03 (t, *J* = 7.2 Hz, 1H, ArH), 7.45 (t, *J* = 7.2 Hz, 1H, ArH), 7.57--7.59 (m, 2H, ArH), 7.63--7.65 (m, 2H, ArH), 7.73 (d, *J* = 7.6 Hz, 1H, ArH), 7.83 (d, *J* = 7.9 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.4, 31.5, 31.7, 35.0, 51.9, 106.5, 117.4, 119.3, 120.1, 122.0, 122.6, 125.8, 127.5, 128.5, 135.3, 146.7, 147.7, 150.6, 151.4, 152.8. MS (ESI+): *m*/*z* = 341.2. ESI-HR-MS calculated for C~24~H~24~N~2~ \[MH\]^+^: 341.2012, found: 341.2017.

### 5-(*m*-Tolyl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aad**) {#sec4.3.4}

Yield: 86% (0.128 g from 0.158 g) as a yellow solid, mp 188--191 °C; *R*~f~ = 0.40 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =2.47--2.56 (m, 5H, CH~3~, CH~2~), 3.42 (t, *J* = 7.6 Hz, 2H, CH~2~), 4.84 (t, *J* = 7.3 Hz, 2H, CH~2~), 6.72 (s, 1H, ArH), 7.00 (t, *J* = 7.4 Hz, 1H, ArH), 7.34--7.35 (m, 1H, ArH), 7.42--7.50 (m, 4H, ArH), 7.65 (d, *J* = 7.8 Hz, 1H, ArH), 7.82 (d, *J* = 8.1 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 21.6, 22.3, 31.6, 51.2, 105.4, 117.9, 118.7, 120.6, 121.9, 123.1, 125.7, 127.2, 128.7, 129.3, 129.8, 138.6, 146.2, 147.1, 151.9, 153.4. MS (ESI+): *m*/*z* = 299.1. ESI-HR-MS calculated for C~21~H~18~N~2~ \[MH\]^+^: 299.1543, found: 299.1542.

### 5-(3-Fluorophenyl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aae**) {#sec4.3.5}

Yield: 87% (0.132 g from 0.160 g) as a yellow solid, mp 198--201 °C; *R*~f~ = 0.56 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =2.49--2.56 (m, 2H, CH~2~), 3.42 (t, *J* = 7.6 Hz, 2H, CH~2~), 4.86 (t, *J* = 7.2 Hz, 2H, CH~2~), 6.69 (s, 1H, ArH), 7.02 (t, *J* = 7.6 Hz, 1H, ArH), 7.21--7.24 (m, 1H, ArH), 7.37 (d, *J* = 9.1 Hz, 1H, ArH), 7.43--7.56 (m, 3H, ArH), 7.61 (d, *J* = 7.9 Hz, 1H, ArH), 7.82 (d, *J* = 8.0 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.3, 31.7, 51.5, 105.1, 115.9 (dd, *J* = 33.4, 21.0 Hz), 118.0, 119.0, 120.7, 121.8, 122.6, 124.5, 127.5, 130.5, 130.6, 140.7, 145.2, 146.5, 151.8, 153.4, 162.9 (d, *J* = 247.3 Hz). MS (ESI+): *m*/*z* = 303.1. ESI-HR-MS calculated for C~20~H~15~FN~2~ \[MH\]^+^: 303.1292, found: 303.1298.

### 5-(2-(Trifluoromethyl)phenyl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aaf**) {#sec4.3.6}

Yield: 84% (0.148 g from 0.185 g) as a yellow solid, mp 208--209 °C; *R*~f~ = 0.72 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =2.49--2.60 (m, 2H, CH~2~), 3.37--3.52 (m, 2H, CH~2~), 4.85--4.89 (m, 2H, CH~2~), 6.71 (s, 1H, ArH), 6.79 (d, *J* = 7.8 Hz, 1H, ArH), 6.89--6.93 (m, 1H, ArH), 7.39--7.48 (m, 2H, ArH), 7.65--7.71 (m, 2H, ArH), 7.79 (d, *J* = 8.2 Hz, 1H, ArH), 7.91--7.93 (m, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.3, 31.7, 51.3, 105.4, 117.8, 119.0, 121.6, 122.4, 123.0, 125.2, 126.6 (dd, *J* = 10.1, 5.1 Hz), 127.4, 128.3 (d, *J* = 30.7 Hz), 128.9, 130.7, 132.1, 137.1, 143.5, 145.6, 152.4 (d, *J* = 189.2 Hz). MS (ESI+): *m*/*z* = 353.1. ESI-HR-MS calculated for C~21~H~15~F~3~N~2~ \[MH\]^+^: 353.1260, found: 353.1266.

### 5-(Phenanthren-9-yl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aag**) {#sec4.3.7}

Yield: 80% (0.154 g from 0.201 g) as a yellow solid, mp 256--259 °C; *R*~f~ = 0.55 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.60--2.67 (m, 2H, CH~2~), 3.51--3.54 (m, 2H, CH~2~), 5.00 (t, *J* = 6.9 Hz, 2H, CH~2~), 6.77 (t, *J* = 7.8 Hz, 1H, ArH), 6.87 (d, *J* = 7.7 Hz, 1H, ArH), 6.93 (s, 1H, ArH), 7.36--7.41 (m, 1H, ArH), 7.43--7.47 (m, 1H, ArH), 7.67--7.74 (m, 3H, ArH), 7.78--7.85 (m, 2H, ArH), 7.90 (s, 1H, ArH), 7.94 (d, *J* = 7.2 Hz, 1H, ArH), 8.84--8.89 (m, 2H, ArH); ^13^C NMR (125 MHz, CDCl~3~): δ (ppm) = 22.3, 31.6, 51.5, 106.8, 117.3, 119.2, 122.2, 122.5, 122.6, 122.7, 123.1, 126.4, 127.0, 127.1, 127.1, 127.2, 127.3, 127.4, 129.0, 129.5, 130.5, 130.6, 131.2, 134.7, 145.3, 146.3, 150.9, 152.2. MS (ESI+): *m*/*z* = 385.2. ESI-HR-MS calculated for C~28~H~20~N~2~ \[MH\]^+^: 385.1699, found: 385.1694.

### 5-(Pyridin-2-yl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aah**) {#sec4.3.8}

Yield: 84% (0.12 g from 0.152 g) as a white solid, mp 198--201 °C; *R*~f~ = 0.30 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, DMSO-*d*~6~): δ (ppm) =2.55--2.60 (m, 2H, CH~2~), 3.59 (t, *J* = 7.4 Hz, 2H, CH~2~), 4.97 (t, *J* = 6.8 Hz, 2H, CH~2~), 7.27 (t, *J* = 7.6 Hz, 1H, ArH), 7.62 (t, *J* = 7.5 Hz, 1H, ArH), 7.71--7.74 (m, 1H, ArH), 7.78 (s, 2H, ArH), 7.87 (d, *J* = 8.0 Hz, 1H, ArH), 8.00 (d, *J* = 7.8 Hz, 1H, ArH), 8.17 (t, *J* = 6.8 Hz, 1H, ArH), 8.94 (d, *J* = 4.2 Hz, 1H, ArH); ^13^C NMR (100 MHz, DMSO-*d*~6~): δ (ppm) = 22.3, 32.1, 55.1, 112.7, 113.4, 117.0, 119.9, 122.5, 123.9, 125.0, 125.8, 129.4, 138.4, 140.1, 143.6, 149.1, 150.6, 152.9, 154.5. MS (ESI+): *m*/*z* = 286.1. ESI-HR-MS calculated for C~19~H~15~N~3~ \[MH\]^+^: 286.1339, found: 286.1338.

### 5-(Thiophen-2-yl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aai**) {#sec4.3.9}

Yield: 80% (0.116 g from 0.154 g) as a yellow solid, mp 201--204 °C; *R*~f~ = 0.35 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, DMSO-*d*~6~): δ (ppm) =2.39--2.47 (m, 2H, CH~2~), 3.42--3.46 (m, 2H, CH~2~), 4.68 (t, *J* = 7.3 Hz, 2H, CH~2~), 6.92 (s, 1H, ArH), 6.99 (t, *J* = 7.2 Hz, 1H, ArH), 7.35--7.38 (m, 2H, ArH), 7.61 (d, *J* = 8.1 Hz, 1H, ArH), 7.71 (d, *J* = 3.2 Hz, 1H, ArH), 7.91 (d, *J* = 5.0 Hz, 1H, ArH), 7.98 (d, *J* = 7.8 Hz, 1H, ArH); ^13^C NMR (100 MHz, DMSO-*d*~6~): δ (ppm) = 22.1, 31.7, 51.6, 105.1, 118.3, 119.0, 121.6, 123.0, 126.9, 128.7, 129.0, 129.2, 138.9, 139.5, 148.0, 152.0, 154.1. MS (ESI+): *m*/*z* = 291.1. ESI-HR-MS calculated for C~18~H~14~N~2~S \[MH\]^+^: 291.0950, found: 291.0953.

### 5-(Cyclohex-1-en-1-yl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aaj**) {#sec4.3.10}

Yield: 81% (0.117 g from 0.153 g) as a yellow solid, mp 212--215 °C; *R*~f~ = 0.55 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =1.84 (d, *J* = 4.6 Hz, 2H, CH~2~), 1.92 (d, *J* = 5.1 Hz, 2H, CH~2~), 2.33 (s, 2H, CH~2~), 2.45--2.48 (m, 4H, 2 × CH~2~), 3.36 (t, *J* = 7.4 Hz, 2H, CH~2~), 4.78 (t, *J* = 7.2 Hz, 2H, CH~2~), 6.14 (s, 1H, =CH), 6.60 (s, 1H, ArH), 7.15 (t, *J* = 7.3 Hz, 1H, ArH), 7.45 (t, *J* = 7.4 Hz, 1H, ArH), 7.81 (d, *J* = 7.9 Hz, 1H, ArH), 8.04 (d, *J* = 7.7 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.2, 22.3, 23.0, 25.5, 28.3, 31.6, 51.2, 104.2, 117.7, 118.9, 119.9, 122.1, 123.2, 126.9, 128.8, 135.7, 146.3, 150.2, 151.6, 152.6. MS (ESI+): *m*/*z* = 289.2. ESI-HR-MS calculated for C~20~H~20~N~2~ \[MH\]^+^: 289.1699, found: 289.1695.

### Methyl 2,3-Dihydro-1*H*-indolizino\[5,6-*b*\]indole-5-carboxylate (**5aak**) {#sec4.3.11}

Yield: 78% (0.104 g from 0.142 g) as a yellow solid, mp 183--186 °C; *R*~f~ = 0.30 (EtOAc/MeOH, 9:1, v/v); IR (KBr) ν~max~: 1729 (CO~2~Me) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =2.48--2.55 (m, 2H, CH~2~), 3.43 (t, *J* = 7.6 Hz, 2H, CH~2~), 4.12 (s, 3H, CH~3~), 4.83 (t, *J* = 7.3 Hz, 2H, CH~2~), 7.22--7.26 (m, 2H, ArH), 7.56 (t, *J* = 7.9 Hz, 1H, ArH), 7.81 (d, *J* = 7.8 Hz, 1H, ArH), 8.64 (d, *J* = 8.0 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.2, 31.7, 51.7, 52.9, 102.9, 118.1, 119.8, 122.2, 123.8, 125.5, 129.0, 132.2, 145.8, 152.9, 155.1, 166.8. MS (ESI+): *m*/*z* = 267.1. ESI-HR-MS calculated for C~16~H~14~N~2~O~2~ \[MH\]^+^: 267.1128, found: 267.1125.

### 7-Methyl-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5baa**) {#sec4.3.12}

Yield: 88% (0.131 g from 0.158 g) as a yellow solid, mp 192--194 °C; *R*~f~ = 0.41 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =2.34 (s, 3H, CH~3~), 2.46--2.54 (m, 2H, CH~2~), 3.40 (t, *J* = 7.7 Hz, 2H, CH~2~), 4.83 (t, *J* = 7.3 Hz, 2H, CH~2~), 6.69 (s, 1H, ArH), 7.28 (s, 1H, ArH), 7.41 (s, 1H, ArH), 7.54--7.59 (m, 3H, ArH), 7.67--7.71 (m, 3H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 21.7, 22.3, 31.7, 51.5, 105.5, 117.3, 120.4, 121.8, 122.9, 128.2, 128.7, 128.8, 128.9, 129.2, 138.6, 146.3, 146.9, 150.7, 151.2. MS (ESI+): *m*/*z* = 299.1. ESI-HR-MS calculated for C~21~H~18~N~2~ \[MH\]^+^: 299.1543, found: 299.1548.

### 7-Methoxy-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5caa**) {#sec4.3.13}

Yield: 92% (0.145 g from 0.166 g) as a yellow solid, mp 212--214 °C; *R*~f~ = 0.38 (EtOAc/MeOH, 9:1, v/v); H NMR (400 MHz, CDCl~3~): δ (ppm) =2.59 (s, 2H, CH~2~), 3.49 (s, 2H, CH~2~), 3.64 (s, 3H, OCH~3~), 5.05 (s, 2H, CH~2~), 6.87 (s, 1H, ArH), 7.02 (s, 1H, ArH), 7.08 (s, 1H, ArH), 7.57--7.65 (m, 5H, ArH), 7.76 (d, *J* = 6.0 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.4, 31.8, 53.4, 55.7, 105.1, 108.2, 116.7, 116.9, 119.2, 121.6, 128.6, 128.9, 129.9, 137.3, 148.4, 149.1, 154.1. MS (ESI+): *m*/*z* = 315.1. ESI-HR-MS calculated for C~21~H~18~N~2~O \[MH\]^+^: 315.1492, found: 315.1493.

### 7-Bromo-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5daa**) {#sec4.3.14}

Yield: 83% (0.151 g from 0.191 g) as a yellow solid, mp 196--197 °C; *R*~f~ = 0.51 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =2.49--2.57 (m, 2H, CH~2~), 3.43 (t, *J* = 7.7 Hz, 2H, CH~2~), 4.81 (t, *J* = 7.3 Hz, 2H, CH~2~), 6.74 (s, 1H, ArH), 7.50 (dd, *J* = 8.6, 2.0 Hz, 1H, ArH), 7.55--7.61 (m, 3H, ArH), 7.65--7.68 (m, 3H, ArH), 7.73 (d, *J* = 2.0 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.3, 31.8, 51.3, 105.7, 111.4, 119.5, 119.8, 124.4, 124.7, 128.5, 129.0, 129.6, 129.9, 138.1, 147.1, 147.9, 152.2, 152.3. MS (ESI+): *m*/*z* = 363.0. ESI-HR-MS calculated for C~20~H~15~BrN~2~ \[MH\]^+^: 363.0491, found: 363.0487.

### 7-Chloro-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5eaa**) {#sec4.3.15}

Yield: 84% (0.134 g from 0.168 g) as a yellow solid, mp 238--241 °C; *R*~f~ = 0.52 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =2.49--2.57 (m, 2H, CH~2~), 3.44 (t, *J* = 7.6 Hz, 2H, CH~2~), 4.82 (t, *J* = 7.3 Hz, 2H, CH~2~), 6.74 (s, 1H, ArH), 7.37 (dd, *J* = 8.5, 2.0 Hz, 1H, ArH), 7.52--7.61 (m, 4H, ArH), 7.66--7.72 (m, 3H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.2, 31.8, 51.3, 105.6, 118.9, 121.4, 123.8, 124.1, 127.3, 128.5, 129.1, 129.5, 138.2, 147.1, 147.8, 152.1, 152.4. MS (ESI+): *m*/*z* = 319.1. ESI-HR-MS calculated for C~20~H~15~ClN~2~ \[MH\]^+^: 319.0997, found: 319.0998.

### 7-Fluoro-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5faa**) {#sec4.3.16}

Yield: 82% (0.124 g from 0.160 mg) as a yellow solid, mp 194--196 °C; *R*~f~ = 0.58 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.50--2.58 (m, 2H, CH~2~), 3.45 (t, *J* = 7.7 Hz, 2H, CH~2~), 4.86 (t, *J* = 7.2 Hz, 2H, CH~2~), 6.76 (s, 1H, ArH), 7.16--7.29 (m, 1H, ArH), 7.25--7.28 (m, 1H, ArH), 7.55--7.60 (m, 3H, ArH), 7.65--7.67 (m, 2H, ArH), 7.73 (dd, *J* = 9.2, 4.8 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.2, 31.8, 51.6, 105.7, 107.4 (d, *J* = 24.8 Hz), 115.2 (d, *J* = 24.9 Hz), 118.1 (d, *J* = 9.0 Hz), 120.3, 122.7 (d, *J* = 10.1 Hz), 128.5, 129.0, 129.5, 138.0, 147.3, 148.1, 148.8, 151.5, 156.9 (d, *J* = 233.7 Hz). MS (ESI+): *m*/*z* = 303.1. ESI-HR-MS calculated for C~20~H~15~FN~2~ \[MH\]^+^: 303.1292, found: 303.1293.

### 7-Nitro-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5gaa**) {#sec4.3.17}

Yield: 81% (0.133 g from 0.174 g) as a yellow solid, mp 202--204 °C; *R*~f~ = 0.31 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.56--2.64 (m, 2H, CH~2~), 3.51 (t, *J* = 7.7 Hz, 2H, CH~2~), 4.89 (t, *J* = 7.5 Hz, 2H, CH~2~), 6.93 (s, 1H, ArH), 7.60--7.76 (m, 6H, ArH), 8.32 (dd, *J* = 9.0, 2.3 Hz, 1H, ArH), 8.62 (d, *J* = 2.2 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.2, 31.9, 51.7, 107.4, 117.6, 118.9, 120.5, 122.4, 122.5, 128.5, 129.3, 130.2, 137.3, 139.9, 148.4, 149.2, 154.5, 157.7. MS (ESI+): *m*/*z* = 330.1. ESI-HR-MS calculated for C~20~H~15~N~3~O~2~ \[MH\]^+^: 330.1237, found: 330.1232.

### 5-Phenyl-7-(trifluoromethoxy)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5haa**) {#sec4.3.18}

Yield: 84% (0.155 g from 0.193 g) as a white solid, mp 196--198 °C; *R*~f~ = 0.70 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, DMSO-*d*~6~): δ (ppm) =2.55--2.63 (m, 2H, CH~2~), 3.59 (t, *J* = 7.5 Hz, 2H, CH~2~), 4.97 (t, *J* = 6.9 Hz, 2H, CH~2~), 7.35 (s, 1H, ArH), 7.61 (d, *J* = 7.6 Hz, 1H, ArH), 7.69--7.76 (m, 6H, ArH), 7.89 (d, *J* = 8.8 Hz, 1H, ArH); ^13^C NMR (100 MHz, DMSO-*d*~6~): δ (ppm) = 22.3, 32.2, 55.2, 113.4, 114.2, 115.1, 116.2, 120.5, 120.9 (d, *J* = 256.4), 122.5, 128.7, 129.8, 131.2, 135.9, 138.2, 143.3, 143.6, 151.9, 154.4. MS (ESI+): *m*/*z* = 369.1. ESI-HR-MS calculated for C~21~H~15~F~3~N~2~O \[MH\]^+^: 369.1209, found: 369.1206.

### 9-Bromo-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5iaa**) {#sec4.3.19}

Yield: 82% (0.149 g from 0.191 g) as a yellow solid, mp 164--167 °C; *R*~f~ = 0.54 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.48--2.56 (m, 2H, CH~2~), 3.44 (t, *J* = 7.6 Hz, 2H, CH~2~), 4.92 (t, *J* = 7.3 Hz, 2H, CH~2~), 6.76 (s, 1H, ArH), 6.84 (t, *J* = 7.8 Hz, 1H, ArH), 7.52--7.59 (m, 4H, ArH), 7.62 (dd, *J* = 7.7, 0.9 Hz, 1H, ArH), 7.65--7.68 (m, 2H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.3, 31.7, 51.3, 105.8, 111.5, 119.2, 120.9, 124.5, 128.5, 128.8, 129.2, 129.6, 138.2, 146.9, 147.9, 151.7, 152.2. MS (ESI+): *m*/*z* = 363.0. ESI-HR-MS calculated for C~20~H~15~BrN~2~ \[MH\]^+^: 363.0491, found: 363.0493.

### 5-Phenyl-9-(trifluoromethyl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5jaa**) {#sec4.3.20}

Yield: 84% (0.148 g from 0.185 g) as a yellow solid, mp 182--184 °C; *R*~f~ = 0.73 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.47--2.55 (m, 2H, CH~2~), 3.43 (t, *J* = 7.6 Hz, 2H, CH~2~), 4.92 (t, *J* = 7.3 Hz, 2H, CH~2~), 6.78 (s, 1H, ArH), 6.99 (t, *J* = 7.7 Hz, 1H, ArH), 7.53--7.60 (m, 3H, ArH), 7.66--7.71 (m, 3H, ArH), 7.76 (d, *J* = 7.8 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.4, 31.8, 51.5, 105.9, 117.1, 118.5 (d, *J* = 31 Hz), 119.8, 124.0 (q, *J* = 5.0 Hz), 125.0, 125.4, 126.6, 128.6, 128.9, 129.3, 138.3, 147.2, 147.7, 150.7, 153.1. MS (ESI+): *m*/*z* = 353.1. ESI-HR-MS calculated for C~21~H~15~F~3~N~2~ \[MH\]^+^: 353.1260, found: 353.1255.

### 7,9-Dimethyl-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5kaa**) {#sec4.3.21}

Yield: 89% (0.139 g from 0.165 g) as a yellow solid, mp 242--245 °C; *R*~f~ = 0.40 (EtOAc/MeOH, 9:1, v/v); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) =2.31 (s, 3H, CH~3~), 2.49--2.52 (m, 2H, CH~2~), 2.75 (s, 3H, CH~3~), 3.41 (t, *J* = 7.5 Hz, 2H, CH~2~), 4.91 (t, *J* = 6.3 Hz, 2H, CH~2~), 6.70 (s, 1H, ArH), 7.11 (s, 1H, ArH), 7.24 (s, 1H, ArH), 7.54--7.58 (m, 3H, ArH), 7.67--7.68 (m, 2H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 18.1, 21.7, 22.5, 51.9, 105.8, 119.3, 120.8, 122.4, 126.3, 128.3, 128.7, 128.8, 129.2, 129.7, 138.6, 146.3, 147.0. MS (ESI+): *m*/*z* = 313.2. ESI-HR-MS calculated for C~22~H~20~N~2~ \[MH\]^+^: 313.1699, found: 313.1701.

General Experimental Procedure for the One-Pot, Two-Step Synthesis of 2,3-Dihydro-1*H*-indolizino\[5,6-*b*\]indoles 5 as Exemplified for **5aaa** {#sec4.4}
-------------------------------------------------------------------------------------------------------------------------------------------------

In a round-bottom flask equipped with a water condenser were added isatin **1a** (0.147 g, 1.0 mmol), [l]{.smallcaps}-proline **2a** (0.115 g, 1.0 mmol), phenylacetylene **3a** (132 μL, 1.2 mmol), and CuI (0.0095 g, 5 mol %) in 5 mL of acetonitrile under nitrogen. The mixture was heated at reflux temperature for 6 h. After completion of the reaction (as monitored by TLC), the solvent was evaporated under reduced pressure to obtain a crude product. To the crude product, POCl~3~ (467 μL, 5.0 mmol) was added and the reaction mixture was heated to 90 °C for 24 h under stirring. On completion, the reaction mixture was neutralized by adding saturated NaHCO~3~ solution and extracted with EtOAc (75 mL × 2). The organic layers were collected, dried over anhydrous Na~2~SO~4~, and evaporated to afford the crude product, which was purified by column chromatography over silica gel using EtOAc/MeOH (80:20, v/v) as eluent to obtain 0.199 g (70%) of **5aaa** as a yellow solid.

### 5-Phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aaa**) {#sec4.4.1}

Yield: 70% (0.199 g from 0.147 g of **1a**) as a yellow solid, mp 257--260 °C.

### 5-(Cyclohex-1-en-1-yl)-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5aaj**) {#sec4.4.2}

Yield: 62% (0.179 g from 0.147 g of **1a**) as a yellow solid, mp 212--215 °C.

### Methyl 2,3-Dihydro-1*H*-indolizino\[5,6-*b*\]indole-5-carboxylate (**5aak**) {#sec4.4.3}

Yield: 58% (0.154 g from 0.147 g of **1a**) as a yellow solid, mp 183--186 °C.

### 7-Methyl-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5baa**) {#sec4.4.4}

Yield: 69% (0.206 g from 0.161 g of **1b**) as a yellow solid, mp 192--194 °C.

### 7-Bromo-5-phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole (**5daa**) {#sec4.4.5}

Yield: 63% (0.228 g from 0.226 g of **1d**) as a yellow solid, mp 196--197 °C.

General Experimental Procedure for the Synthesis of 1-Substituted-1*H*-α-carbolines **5** {#sec4.5}
-----------------------------------------------------------------------------------------

In a round-bottom flask equipped with a water condenser were added isatin **1a** (0.147 g, 1.0 mmol), α-amino acid **2** (1.0 mmol), and dipolarophile **3** (1.0 mmol) in 5 mL of methanol, and the mixture was heated at reflux temperature. After completion (as monitored by TLC), the solvent was removed under reduced pressure to obtain the crude product, to which POCl~3~ (5--10 mmol) was added, and the mixture was heated at 90 °C under stirring. On completion (as assessed by TLC), the reaction mixture was neutralized by adding saturated NaHCO~3~ solution and extracted with EtOAc (75 mL × 2). The organic layers were combined, dried over anhydrous Na~2~SO~4~, and evaporated to furnish the crude material, which was purified by column chromatography over silica gel using EtOAc/MeOH (80:20, v/v) as eluent to afford the appropriate product **5**.

### Dimethyl 2,3-Dihydro-1*H*-indolizino\[5,6-*b*\]indole-4,5-dicarboxylate (**5aam**) {#sec4.5.1}

Yield: 82% (0.266 g) as a yellow solid, mp 229--232 °C; *R*~f~ = 0.49 (EtOAc/MeOH, 9:1, v/v); IR (KBr) ν~max~: 1714 (CO~2~Me), 1736 (CO~2~Me) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.47--2.55 (m, 2H, CH~2~), 3.79 (t, *J* = 7.8 Hz, 2H, CH~2~), 3.93 (s, 3H, CH~3~), 4.13 (s, 3H, CH~3~), 4.79 (t, *J* = 7.6 Hz, 2H, CH~2~), 7.24--7.27 (m, 1H, ArH), 7.53--7.57 (m, 1H, ArH), 7.80 (d, *J* = 8.1 Hz, 1H, ArH), 7.85 (d, *J* = 7.8 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 21.4, 34.3, 51.8, 52.5, 53.1, 104.2, 118.8, 121.0, 121.6, 121.9, 122.3, 129.1, 134.9, 152.1, 152.2, 154.7, 165.2, 167.6. MS (ESI+): *m*/*z* = 325.1. ESI-HR-MS calculated for C~18~H~16~N~2~O~4~ \[MH\]^+^: 325.1183, found: 325.1183.

### Diethyl 2,3-Dihydro-1*H*-indolizino\[5,6-*b*\]indole-4,5-dicarboxylate (**5aan**) {#sec4.5.2}

Yield: 80% (0.282 g) as a yellow solid, mp 214--217 °C; *R*~f~ = 0.52 (EtOAc/MeOH, 9:1, v/v); IR (KBr) ν~max~: 1714 (CO~2~Et), 1736 (CO~2~Et) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 1.39--1.48 (m, 6H, 2 × CH~3~), 2.46--2.54 (m, 2H, CH~2~), 3.80 (t, *J* = 7.8 Hz, 2H, CH~2~), 4.37--4.42 (m, 2H, CH~2~), 4.58--4.64 (m, 2H, CH~2~), 4.79 (t, *J* = 7.5 Hz, 2H, CH~2~), 7.23--7.27 (m, 1H, ArH), 7.53--7.57 (m, 1H, ArH), 7.80 (d, *J* = 8.1 Hz, 1H, ArH), 7.89 (d, *J* = 7.8 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 14.2, 14.3, 21.5, 34.3, 51.7, 61.6, 62.3, 104.5, 118.8, 120.8, 121.5, 122.0, 122.5, 128.9, 135.3, 152.1, 154.7, 164.8, 167.1. MS (ESI+): *m*/*z* = 353.1. ESI-HR-MS calculated for C~20~H~20~N~2~O~4~ \[MH\]^+^: 353.1496, found: 353.1497.

### Ethyl 5-Phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indole-4-carboxylate (**5aao**) {#sec4.5.3}

Yield: 79% (0.281 g) as a yellow solid, mp 180--184 °C; *R*~f~ = 0.38 (EtOAc/MeOH, 9:1, v/v); IR (KBr) ν~max~: 1700 (CO~2~Et) cm^--1^. ^1^H NMR (400 MHz, DMSO-*d*~6~): δ (ppm) = 0.82 (t, *J* = 7.1 Hz, 3H, CH~3~), 2.41--2.48 (m, 2H, CH~2~), 3.03 (t, *J* = 7.6 Hz, 2H, CH~2~), 3.91--3.96 (m, 2H, CH~2~), 4.73 (t, *J* = 7.4 Hz, 2H, CH~2~), 6.77 (d, *J* = 7.7 Hz, 1H, ArH), 6.85 (t, *J* = 7.3 Hz, 1H, ArH), 7.32--7.41 (m, 3H, ArH), 7.57--7.65 (m, 4H, ArH); ^13^C NMR (100 MHz, DMSO-*d*~6~): δ (ppm) = 13.7, 21.7, 33.6, 52.1, 60.7, 109.0, 118.4, 119.2, 121.6, 121.8, 124.2, 127.4, 127.8, 128.5, 128.8, 138.3, 145.4, 151.2, 151.8, 154.5, 166.2. MS (ESI+): *m*/*z* = 357.2. ESI-HR-MS calculated for C~23~H~20~N~2~O~2~ \[MH\]^+^: 357.1598, found: 357.1599.

### Dimethyl 1,3-Dihydrothiazolo\[3′,4′:1,6\]pyrido\[2,3-*b*\]indole-4,5-dicarboxylate (**5abm**) {#sec4.5.4}

Yield: 68% (0.233 g) as a yellow solid, mp 164--166 °C; *R*~f~ = 0.51 (hexanes/EtOAc, 1:90, v/v); IR (KBr) ν~max~: 1703 (CO~2~Me), 1722 (CO~2~Me) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 3.94 (s, 3H, CH~3~), 4.12 (s, 3H, CH~3~), 4.96 (s, 2H, CH~2~), 5.84 (s, 2H, CH~2~), 7.26--7.31 (m, 1H, ArH), 7.59 (t, *J* = 7.4 Hz, 1H, ArH), 7.79 (d, *J* = 7.9 Hz, 1H, ArH), 7.88 (d, *J* = 7.5 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 37.8, 52.9, 53.2, 54.0, 104.9, 119.0, 121.5, 122.2, 122.3, 122.7, 129.8, 134.2, 148.2, 152.1, 154.9, 164.9, 167.0. MS (ESI+): *m*/*z* = 343.1. ESI-HR-MS calculated for C~17~H~14~N~2~O~4~S \[MH\]^+^: 343.0747, found: 343.0744.

### Dimethyl 1-Methyl-1*H*-pyrido\[2,3-*b*\]indole-3,4-dicarboxylate (**5aem**) {#sec4.5.5}

Yield: 77% (0.229 g) as a yellow solid, mp 201--203 °C; *R*~f~ = 0.62 (EtOAc/MeOH, 9:1, v/v); IR (KBr) ν~max~: 1709 (CO~2~Me), 1739 (CO~2~Me) cm^--1^. ^1^H NMR (500 MHz, CDCl~3~): δ (ppm) = 3.93 (s, 3H, CH~3~), 4.15 (s, 3H, CH~3~), 4.31 (s, 3H, CH~3~), 7.26--7.29 (m, 1H, ArH), 7.59 (t, *J* = 7.2 Hz, 1H, ArH), 7.82 (d, *J* = 8.1 Hz, 1H, ArH), 7.88 (d, *J* = 7.8 Hz, 1H, ArH), 8.53 (s, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 40.8, 52.5, 53.2, 107.2, 118.9, 121.1, 122.0, 122.2, 123.0, 129.6, 133.4, 138.3, 153.7, 154.5, 164.2, 166.9. MS (ESI+): *m*/*z* = 299.1. ESI-HR-MS calculated for C~16~H~14~N~2~O~4~ \[MH\]^+^: 299.1026, found: 299.1024.

### 8,9-Dihydro-7*H*-benzo\[*g*\]indolo\[2,3-*c*\]pyrrolo\[2,1-*a*\]isoquinoline-10,15-dione (**5aar**) {#sec4.5.6}

Yield: 74% (0.250 g) as a dark brown solid, mp 278--282 °C; *R*~f~ = 0.29 (EtOAc/MeOH, 9:1, v/v); IR (KBr) ν~max~: 1653 (C=O), 1675 (C=O) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.51--2.59 (m, 2H, CH~2~), 3.98 (t, *J* = 7.9 Hz, 2H, CH~2~), 4.79 (t, *J* = 7.9 Hz, 2H, CH~2~), 7.33 (t, *J* = 8.1 Hz, 1H, ArH), 7.60 (t, *J* = 7.2 Hz, 1H, ArH), 7.72 (d, *J* = 7.9 Hz, 1H, ArH), 7.79--7.84 (m, 2H, ArH), 8.27--8.29 (m, 1H, ArH), 8.33--8.35 (m, 1H, ArH), 9.28 (d, *J* = 8.1 Hz, 1H, ArH); ^13^C NMR = the compound is too insoluble. MS (ESI+): *m*/*z* = 339.1. ESI-HR-MS calculated for C~22~H~14~N~2~O~2~ \[MH\]^+^: 339.1128, found: 339.1124.

### 1-(4-Phenyl-2,3-dihydro-1*H*-indolizino\[5,6-*b*\]indol-5-yl)ethanone (**5aas**) {#sec4.5.7}

Yield: 70% (0.228 g) as a yellow solid, mp 214--217 °C; *R*~f~ = 0.39 (EtOAc/MeOH, 9:1, v/v); IR (KBr) ν~max~: 1675 (COMe) cm^--1^. ^1^H NMR (500 MHz, CDCl~3~): δ (ppm) = 2.18 (s, 3H, COCH~3~), 2.47 (t, *J* = 7.1 Hz, 2H, CH~2~), 3.30 (t, *J* = 7.3 Hz, 2H, CH~2~), 4.91 (t, *J* = 6.9 Hz, 2H, CH~2~), 7.18 (t, *J* = 7.2 Hz, 1H, ArH), 7.35 (d, *J* = 6.8 Hz, 2H, ArH), 7.43--7.53 (m, 4H, ArH), 7.81 (t, *J* = 10.1 Hz, 2H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 22.1, 31.1, 31.8, 52.1, 114.1, 118.1, 119.6, 121.6, 128.2, 128.3, 129.0, 130.2, 135.3, 143.9, 145.3, 151.4, 154.0, 203.6. MS (ESI+): *m*/*z* = 327.1. ESI-HR-MS calculated for C~22~H~18~N~2~O \[MH\]^+^: 327.1492, found: 327.1493.

### 2,3-Dihydro-1*H*-indolizino\[5,6-*b*\]indole-5-carbonitrile (**5aat**) {#sec4.5.8}

Yield: 73% (0.170 g) as a red solid, mp 260--264 °C; *R*~f~ = 0.37 (EtOAc/MeOH, 9:1, v/v); IR (KBr) ν~max~: 2357 (CN) cm^--1^. ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) = 2.40--2.47 (m, 2H, CH~2~), 3.30 (t, *J* = 7.7 Hz, 2H, CH~2~), 4.68 (t, *J* = 7.4 Hz, 2H, CH~2~), 6.70 (s, 1H, ArH), 7.27--7.31 (m, 1H, ArH), 7.56--7.60 (m, 1H, ArH), 7.76 (d, *J* = 8.2 Hz, 1H, ArH), 8.33 (d, *J* = 7.8 Hz, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) = 21.9, 31.5, 51.5, 102.8, 110.8, 116.2, 118.4, 120.3, 121.3, 122.1, 127.0, 129.9, 146.5, 151.1, 155.0. MS (ESI+): *m*/*z* = 234.1. ESI-HR-MS calculated for C~15~H~11~N~3~ \[MH\]^+^: 234.1026, found: 234.1028.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b00396](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b00396).^1^H and ^13^C NMR data and HRMS images; X-ray crystallographic analysis of **5aaf**; and SB-SI-carbolines ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00396/suppl_file/ao9b00396_si_001.pdf))Compd. **5aaf** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00396/suppl_file/ao9b00396_si_002.cif))
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